DOI: 10.36871/vet.zoo.bio.202103004
UDC 617.711-002: 636.2
Authors
N. V. Pimenov
Professor of the Russian Academy of Sciences, Doctor of Biological
Sciences, Moscow State Academy of Veterinary Medicine
and Biotechnology – MVA by K. I. Skryabin»,
Moscow, Russian Federation
M. Aref Agah
Teaching Assistant, Faculty of Agriculture, Badgis University,
Qala i Naw city, Badghis, Afghanistan
Research Student, Faculty of Veterinary Medicine, Department of Biology
and Pathology of Small Domestic, Laboratory and Exotic Animals,
Moscow State Academy of Veterinary Medicine
and Biotechnology – MVA by K.I. Skryabin»,
Moscow, Russian Federation
G. Sh. Navruzshoeva
Candidate of Veterinary Sciences, Associate Professor,
Moscow State Academy of Veterinary Medicine
and Biotechnology – MVA by K.I. Skryabin»,
Moscow, Russian Federation
Abstract
Infectious bovine keratoconjunctivitis (IBK) is a bacterial eye disease affecting cattle worldwide.
The main etiological role in IBK belongs to Moraxella spp. (including in associations with Staphylococcus
spp., Streptococcus spp., Pseudomonas aeruginosa, E. coli, Proteus). Persistence factors
and antimicrobial resistance of these bacteria, reduce the effectiveness of traditional treatment
measures for IBK.
New strategies for combating bacterial infections set up prospects for the use of bacteriophages.
The paper presents data substantiating the relevance of the development of a therapeutic and prophylactic
method of phage processing and an agent based on lytically properties of bacteriophages
to combat infectious keratoconjunctivitis in cattle.
Keywords
Infectious bovine keratoconjunctivitis, cattle, bacteriophage, phage therapy, antimicrobial resistance.